In this final segment of Market Checkup, the Motley Fool's health-care focused investing show, analyst David Williamson explains why small-cap Cambrex Corporation is on his watchlist.
Headquartered right next to Super Bowl site MetLife Stadium, Cambrex is a life sciences company focused on making active pharmaceutical ingredients. Essentially, it makes the drugs the drug companies sell. In many ways Cambrex is almost more of an industrial stock than a health-care stock.
In this video, David highlights Cambrex's financial performance, why a mystery client has the rumor mill buzzing, and why investors should watch Cambrex's quaterly results.